Compound class:
Synthetic organic
Comment: We obtained the chemical structure for culmerciclib from the WHO's proposed INN list 127 (21 July 2022). In this document it was described as a cyclin-dependent kinase inhibitor and antineoplastic. This Chemical structure mapped to PubChem CID 122544510, and to a structure in Nanjing Mingde New Drug Research and Development Company's patent WO2016141881A1 [1] which claims selective CDK4/6 inhibitors as anticancer drugs.
|
|
Classification ![]() |
|
Compound class | Synthetic organic |
IUPAC Name ![]() |
5-fluoro-4-(2-methyl-3-propan-2-ylindazol-5-yl)-N-(5-piperazin-1-ylpyridin-2-yl)pyrimidin-2-amine |
International Nonproprietary Names ![]() |
|
INN number | INN |
12183 | culmerciclib |
Database Links ![]() |
|
GtoPdb PubChem SID | 472319199 |
PubChem CID | 122544510 |
Search Google for chemical match using the InChIKey | LLFOBMRPWNABCB-UHFFFAOYSA-N |
Search Google for chemicals with the same backbone | LLFOBMRPWNABCB |
Search PubMed clinical trials | culmerciclib |
Search PubMed titles | culmerciclib |
Search PubMed titles/abstracts | culmerciclib |
UniChem Compound Search for chemical match using the InChIKey | LLFOBMRPWNABCB-UHFFFAOYSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | LLFOBMRPWNABCB-UHFFFAOYSA-N |